Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Microba Life Sciences's Dividends Received for the
six
months ended in Dec. 2025 was €0.00 Mil.
Microba Life Sciences's Dividends Received for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil.
Microba Life Sciences Dividends Received Related Terms
Microba Life Sciences Dividends Received Historical Data
* Premium members only.
The historical data trend for Microba Life Sciences's Dividends Received can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Microba Life Sciences Dividends Received Calculation
A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Dividends Received represents dividend received on the investment in the direct cash flow method.
Dividends Received for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Microba Life Sciences (FRA:F3Y) has a Dividends Received of €0.00 Mil as of Dec. 2025. Dividends Received represents dividend received on the investment in direct cash flow method. View historical data for Microba Life Sciences and its competitors.
Is Microba Life Sciences' Dividends Received too high?
Microba Life Sciences' current Dividends Received is €0.00 Mil. Overall, Microba Life Sciences has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Microba Life Sciences' Dividends Received compare to TMO and DHR?
Microba Life Sciences' Dividends Received of €0.00 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends Received for a Medical Diagnostics & Research company?
A good Dividends Received depends on the Medical Diagnostics & Research industry context. However, Dividends Received should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends Received mean?
A high Dividends Received can signal that a stock is expensive relative to its fundamentals. Dividends Received represents dividend received on the investment in direct cash flow method. View historical data for Microba Life Sciences and its competitors. Microba Life Sciences's current Dividends Received is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microba Life Sciences stock overvalued right now?
Microba Life Sciences (FRA:F3Y) has a current Dividends Received of €0.00 Mil. The stock's GF Value™ is €0.12, compared to a current price of €0.02 — trading 81.3% below its estimated fair value. The current Dividends Received is €0.00 Mil. Microba Life Sciences' overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends Received calculated?
Dividends Received is calculated from a company's financial statements. For Microba Life Sciences (FRA:F3Y), the current Dividends Received is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Microba Life Sciences (FRA:F3Y) Overvalued in 2026?
Based on GuruFocus' analysis, Microba Life Sciences stock appears to be undervalued.
The current stock price of €0.02 is trading 81.3% below its estimated GF Value™ of €0.12.
Key valuation signals for FRA:F3Y:
Dividends Received: €0.00 Mil
GF Value™: €0.12 vs. price of €0.02 (81.3% below fair value)
No single metric tells the full story. See the FRA:F3Y stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome and engages in providing gut microbiome testing services globally to consumers, clinicians, and researchers. It is also involved in developing new pathology services, therapeutics, and diagnostics based on the human gut microbiome. The company's operating segments are: Testing Services and Supplements, which derive key revenue, and Research and Development. Geographically, the company derives maximum revenue from Australia and the rest from Europe, New Zealand, the United States, Asia, and other regions.
29GF Score
Get the complete analysis for FRA:F3Y
Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:F3Y has been successfully added to your 
